13107-20-5

Basic information

• Product Name: (2-phenoxyphenyl)lithium
• Synonyms: (2-phenoxyphenyl)lithium
• CAS NO: 13107-20-5
• Molecular Weight: 176.144
• Mol File: 13107-20-5.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: (2-phenoxyphenyl)lithium(CAS DataBase Reference)
• NIST Chemistry Reference: (2-phenoxyphenyl)lithium(13107-20-5)
• EPA Substance Registry System: (2-phenoxyphenyl)lithium(13107-20-5)

Safety Data

• Hazardous Substances Data: 13107-20-5(Hazardous Substances Data)

Upstream product

• 7025-06-1 1-bromo-2-phenoxybenzene 
• 101-84-8 diphenylether 

Downstream Products

• 18827-32-2 tetrakis-(2-phenoxy-phenyl)-silane 
• 117756-05-5 tris-(2-phenoxy-phenyl)-phenyl-silane 
• 101-84-8 diphenylether 
• 54826-28-7 2,3,4,5,6-Pentafluor-2'-phenoxybiphenyl 
• 183383-68-8 2-phenoxyphenyldiphenylphosphine 
• 950584-54-0 2-(2-phenoxyphenyl)-2-cyclohexenone 
• 1225-16-7 10-phenyl-10H-phenoxaphosphinine 
• 603-35-0 triphenylphosphine 
• 55710-19-5 2-phenoxybenzenethiol 
• 1071018-55-7 ((1R,3S)-3-(tert-butoxycarbonylamino)cyclopentyl)((3R)-3-(1-hydroxy-5-methoxy-1-(2-phenoxyphenyl)pentyl)piperidin-1-yl)methanone 
• 1071017-32-7 1-((3R)-1-{[(1R,3S)-3-aminocyclopentyl]carbonyl}-3-piperidinyl)-5-(methyloxy)-1[2-(phenyloxy)phenyl]-1-pentanol 
• 1071018-45-5 (3R)-tert-butyl 3-(1-hydroxy-5-methoxy-1-(2-phenoxyphenyl)pentyl)piperidine-1-carboxylate 
• 884514-26-5 5-methoxy-1-(2-phenoxyphenyl)-1-((R)-piperidin-3-yl)pentan-1-ol 
• 1609484-45-8 4-bromospiro[fluorene-9,9′-xanthene] 

Relevant articles and documents

Synthetic method of 4-bromine spiro[fluorine-9,9'-xanthene]

The invention discloses a synthetic method of 4-bromine spiro[fluorine-9,9'-xanthene] and belongs to the field of organic synthesis. The synthetic method is realized by the following steps: taking diphenyl ether as a raw material, and enabling the dipheny

RENIN INHIBITORS

Disclosed are compounds of Formula I, wherein the R, R1, R2, R3, X, Y, A, Q, E, and G are defined herein. These compounds bind to aspartic proteases to inhibit their activity and are useful in the treatment or amelioration

PIPERIDINE AND MORPHOLINE RENIN INHIBITORS

Described are compounds which are orally active and bind to renin to inhibit its activity. They are useful in the treatment or amelioration of diseases associated with renin activity. Also described are methods of use of these compounds for treating or ameliorating a renin mediated disorder in a subject.